Recombinant Human Erythropoietin alpha

BIOLOGICAL2 trials

Sponsors

Cadila Pharnmaceuticals, PT. Daewoong Infion

Conditions

AnemiaChronic Kidney Disease (CKD)

Phase 3

Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure

CompletedNCT00399269

Cadila PharnmaceuticalsAnemia

Start: 2006-12-31End: 2007-06-30Updated: 2009-06-11

Unknown Phase

The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®

CompletedNCT05373303

PT. Daewoong InfionChronic Kidney Disease (CKD)

Start: 2019-11-07End: 2022-01-28Updated: 2022-07-14